Skip to main content
Home

Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Money dollar investments

Cardiologist compensation in the United States is experiencing slow, but steady growth. How does it compare to other specialties? 

  • Read more about Salary update: Cardiologist compensation stays steady—thoracic surgeon pay takes a hit

Radiology among 4 specialties seeing greatest year-over-year pay gains: Doximity

Radiology x-ray money scan dollar

In 2024, the average radiologist saw their compensation climb about 7.5%, up to $571,749, behind only pediatric nephrology (15.6%), preventive medicine (10%), and pediatrics/general medicine (8.5%).  

  • Read more about Radiology among 4 specialties seeing greatest year-over-year pay gains: Doximity

Imaging experts warn of challenges implementing CMS radiology quality measure

Voluntary reporting started in January, while mandatory compliance is slated to begin in 2027, experts write in the Journal of the American College of Radiology.  

  • Read more about Imaging experts warn of challenges implementing CMS radiology quality measure

Yale names new radiology chair, Rad Partners’ board addition, plus more leadership moves from ASTRO, Merit Medical

Christopher Whitlow, MD, PhD, MHA Yale

Christopher Whitlow, MD, PhD, MHA

Christopher Whitlow, MD, is the Ivy League institution's new radiology leader, while John Chiminski joins the RP board, and Catheryn M. Yashar, MD, is set to become ASTRO president. 

  • Read more about Yale names new radiology chair, Rad Partners’ board addition, plus more leadership moves from ASTRO, Merit Medical

President outlines public-private vision for mass digitizing of health data, reinstates Presidential Fitness Test for youth

presidential fitness test

What President Trump has in mind is a populace equipped with smartphone apps run by tech companies and confident enough in those apps to willingly upload much if not all of their personal health data. All that and fit kids too. 

  • Read more about President outlines public-private vision for mass digitizing of health data, reinstates Presidential Fitness Test for youth

MRI biomarker could identify patients at risk of cognitive decline post-stroke

MRI biomarkers predict cognitive impairment post-stroke

A new study’s findings highlight the potential for imaging biomarkers to help guide post-stroke care decisions in the future. 

  • Read more about MRI biomarker could identify patients at risk of cognitive decline post-stroke

The most anticipated trials at ESC 2025

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.ESC Congress 2022 European Society of Cardiology. #ESC #ESC2025 #ESC25
Image courtesy of the European Society of Cardiology.

The European Society of Cardiology 2025 congress includes 10 Hot Line sessions and 28 late-breaking science sessions to showcase the latest science.

  • Read more about The most anticipated trials at ESC 2025

New details surrounding fatal Long Island MRI accident prompt more questions

MRI safety zone warning sign at entrance into an MRI imaging room at Northwestern Central DuPage Hospital.

New information indicates Nassau Open MRI has closed circuit video cameras throughout its facility, including in the control room of the MRI trailer attached to the building where the accident took place. 

  • Read more about New details surrounding fatal Long Island MRI accident prompt more questions

Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Tirzepatide, a once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide receptor agonist (GLP-1), has been approved by the U.S. Food & Drug Administration (FDA) for improving glycemic control among adults with type 2 diabetes. The medication, sold by Eli Lilly and Company under the name Mounjaro, will be available in six different doses and come in an auto-injector pen.

Tirzepatide met the primary endpoint of non-inferiority versus dulaglutide, with an 8% lower rate of MACE events included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight.

  • Read more about Tirzepatide demonstrates cardiovascular protection in head-to-head trial with dulaglutide

Pilot study looks at same-day discharge PCI for acute coronary syndromes

Interventional cardiologists performing PCI

Photo courtesy of Jose Arellano.

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients. 

  • Read more about Pilot study looks at same-day discharge PCI for acute coronary syndromes

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …231
    • Page 232
    • Page 233
    • Page 234
    • Current page 235
    • Page 236
    • Page 237
    • Page 238
    • Page 239 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme